2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC334
  



  

  
Submitter : 
  

  
Dr. James Abernathy
  

  
Date & Time: 
  

  
01/26/2006 02:01:35
  



  

  
Organization : 
  

  
Abernathy Longevity Systems
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Clarification of the boundaries within which a pharmacy provides service needs to be clarified and published clearly for the lay-public. It appears that the need to control compounding tends to be aggravated by private interests, like drug manufacturers who want to control the marketplace, which is a terrible injustice to Americans.